KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations.

Nat Commun · 2025-Dec-03 · PMID 41339316

Panel D_7提取完成待 EXE 对齐验证

PFS

Fig. 3. Association between clinical outcomes with atezolizumab-bevacizumab-chemotherapy combinations and NMF subtype in IMpower150. a PFS in each treatment arm by NMF subtype. The forest plot shows the PFS HRs for ABCP vs BCP for each subtype. b OS in each treatment arm by NMF subtype. The forest plot shows the OS HRs for ABCP vs BCP. c Comparison of PFS across NMF subtypes by treatment. d Comparison of PFS (top 3 panels) and OS (bottom 3 panels) with ABCP vs BCP in NMF2 and NMF4 subtypes by PD-L1 level: PD-L1–high (tumour proportion score ≥ 50% by SP263 IHC assay), PD-L1–low (1%-49%) and PD-L1–negative (< 1%). Data in the ACP arm were not substantially different from those in the BCP arm and are not shown in the graphs to aid visualization. e Results of the multivariate analysis evaluating the association between the outcomes (PFS: left panel, and OS: right panel) and multiple factors on the ABCP arm. These factors include NMF subtypes, PD-L1 levels, tumor mutation burden, STK11/KEAP1 mutational status, and smoking history. Source data are provided as a Source Data file. For the forest plots in a,b , e , each row represents a different predictor variable, with the point estimates and 95% CIs for the HRs displayed as squares and horizontal error bars, respectively. The vertical dashed line represents the line of no effect (HR = 1.0). Variables with confidence intervals that do not cross this line are considered statistically significant. For the survival analyses in a , b , e , the log-rank test was used to compare Kaplan-Meier survival curves. Cox proportional hazards regression models were used to generate hazard ratios and 95% confidence intervals. Multivariable Cox proportional hazards regression models were used to compare the interdependence of distinct biomarkers for prediction of OS benefit. ABCP atezolizumab plus bevacizumab plus carboplatin-paclitaxel, ACP atezolizumab plus carboplatin-paclitaxel, BCP bevacizumab plus carboplatin-paclitaxel, NE not estimable.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.79
质量通过是
预期曲线2
实际曲线2
X 范围5.49e+13 – 8.12e+14
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 83 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.00001.000054855056484251.6172560
120.03031.0000109710112968503.2344610
130.03641.0000120681124265353.5469620
140.04241.0000131652135562203.8750630
150.04851.0000142623146859054.1875640
160.05451.0000153594158155904.5312650
170.06061.0000164565169452754.8438660
180.06671.0000175536180749605.1875670
190.07271.0000186507192046455.5000680
1100.07880.9693197478203343305.8125695
1110.08480.8896208449214640156.15627018
1120.09090.8712219420225937006.46887121
1130.09700.8405230391237233856.78127226
1140.10300.8405241362248530707.09387326
1150.10910.8405252333259827557.40627426
1160.11520.7853263304271124407.75007535
1170.12120.7853274275282421258.06257635
1180.12730.7853285246293718108.37507735
1190.13330.7853296217305014958.75007835
1200.13940.7853307188316311809.06257935
1210.14550.7853318159327608659.37508035
1220.15150.7301329130338905509.68758144
1230.15760.6810340101350202360.00008252
1240.16360.6687351072361499210.37508354
1250.16970.6258362043372796060.68758461
1260.17580.6258373014384092911.00008561
1270.18180.6258383985395389761.31258661
1280.18790.6258394956406686611.62508761
1290.19390.6258405927417983461.93758861
1300.20000.6258416898429280312.31258961
1310.20610.6258427869440577162.62509061
1320.21210.6258438840451874012.93759161
1330.21820.6258449811463170863.25009261
1340.22420.6258460782474467713.56259361
1350.23030.6258471753485764563.87509461
1360.23640.6258482724497061414.18759561
1370.24240.6258493695508358264.50009661
1380.24850.6258504666519655114.81259761
1390.25450.6258515637530951965.18759861
1400.26060.6258526608542248815.50009961
1410.26670.6258537579553545665.812510061
1420.27270.6258548550564842516.125010161
1430.27880.6258559521576139366.437510261
1440.28480.6258570492587436216.750010361
1450.29090.6258581463598733067.125010461
1460.29700.6258592434610029917.500010561
1470.30300.6258603405621326767.750010661
1480.30910.6258614376632623618.125010761
1490.31520.6258625347643920468.375010861
1500.32120.6258636318655217318.750010961
1510.32730.6258647289666514169.000011061
1520.33330.6258658260677811019.375011161
1530.33940.6258669231689107869.625011261
1540.34550.6258680202700404720.000011361
1550.35150.6258691173711701570.250011461
1560.35760.6258702144722998420.750011561
1570.36360.6258713115734295271.000011661
1580.36970.6258724086745592121.375011761
1590.37580.6258735057756888971.625011861
1600.38180.6258746028768185822.000011961
1610.38790.6258756999779482672.250012061
1620.39390.6258767970790779522.625012161
1630.40000.6258778941802076372.875012261
1640.40610.6258789912813373223.250012361
1650.41210.6258800883824670073.500012461
1660.41820.6258811854835966923.875012561
210.00000.429454855056484251.61725693
220.01210.429476797079077952.26565893
230.01820.429487768090374802.59385993
240.02420.429498739101671652.90626093
250.03030.4294109710112968503.23446193
260.03640.4294120681124265353.54696293
270.04240.4294131652135562203.87506393
280.04850.4294142623146859054.18756493
290.05450.4294153594158155904.53126593
2100.06060.4294164565169452754.84386693
2110.06670.4294175536180749605.18756793
2120.07270.4294186507192046455.50006893
2130.07880.4233197478203343305.81256994
2140.08480.4233208449214640156.15627094
2150.09090.4233219420225937006.46887194
2160.09700.4233230391237233856.78127294
2170.10300.4233241362248530707.09387394
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-23T17:08:19+00:00